NEWS
Mar 27, 2026

SSRP Institute Welcomes Medivive as New Trusted Partner

PARTNER ANNOUNCEMENT

WILLOUGHBY, Ohio, [March 27, 2026] — The SSRP Institute is pleased to announce that Medivive has joined its Trusted Partner Network following nomination and internal vetting aligned with SSRP’s mission of advancing science-first, education-driven clinical collaboration.

Medivive offers an advanced approach to NAD⁺ therapy designed to support cellular energetics through sterile, clinician-prescribed formulations produced under current Good Manufacturing Practices (cGMP) and dispensed by licensed pharmacies. Delivered subcutaneously, Medivive’s NAD⁺ therapy is designed to improve bioavailability compared to oral precursors while supporting tissue energy production and redox balance under medical supervision.

Jay Palmer, CEO and Co-Founder of Medivive says, "Dr. Seeds and I have known each other for a while, and when we started talking about what Medivive was building, the fit was obvious. SSRP practitioners hold their protocols to a high standard, and the Medivive pen was built to match it. This is the first prefilled NAD+ subcutaneous injector pen manufactured to cGMP standards at a 503B outsourcing facility in the US. Drug-grade testing on every batch, delivered the right way, with zero burden on the practice. We are proud to be the preferred NAD+ provider for this community." 

"Now, we can feel more confident in measuring and following the evidence on this with a safe product,” Dr. William Seeds, Founder and Academic Chairman of the SSRP Institute said recently on Episode 50 of his podcast, Redox Revolution. “This really opens the door to some powerful things you can start doing as you work to help that patient. I mean, it's things that I have not been able to do for a very long time.”

Certificates of Analysis covering potency, sterility, and endotoxin testing are maintained for every batch and are available to prescribers upon request. Medivive’s dedicated Partner Page is now live and provides SSRP Members with information about their offerings, research background, and ways they support clinical practice.

For more information and to view the Medivive Partner Page, visit:
SSRP Medivive Partner Page


About the SSRP Institute

The SSRP Institute is an education-focused organization dedicated to advancing cellular medicine through evidence-based training, professional collaboration, and clinically relevant research. SSRP supports providers worldwide through certifications, events, and ongoing educational programming designed to improve patient outcomes and elevate the standard of care.

The SSRP Trusted Partner Network is invitation-only and based on real-world clinical relevance, thoughtful nomination, and alignment with SSRP’s educational principles. Partners are integrated through a structured process designed to foster collaboration, support clinician education, and strengthen the implementation of cellular medicine practices.

RELATED RESOURCES

Continue exploring related topics.

VIEW ALL
ARTICLE
William Seeds, MD
Apr 21, 2026
A Review of Circadian Processes and Evidence-Based Interventions to Improve Sleep
William Seeds, MD Apr 21, 2026
A Review of Circadian Processes and Evidence-Based Interventions to Improve Sleep
Introduction In March of this year, I did a Rabbit Hole (Episode 079) in which I discussed a number of trends marketed to the wider public promising sleep improvement. As you know, a huge swath of the population suffers from sleep disturbance. According to the NIH, approximately 30% to 40% of US adults report sleep […]
READ ARTICLE
VIDEO
Cellular Medicine Mondays
Apr 20, 2026
Ep. 084 - The Cellular Impact of UVA vs. UVB Light (Part 2)
Preview Only
Rabbit Holes – Episode 084

The Cellular Impact of UVA vs. UVB Light (Part 2)

Dr. Seeds continues this Rabbit Hole on UVA vs. UVB light in Part 2, covering oxidative stress, skin aging, vitamin D synthesis, and the risks of tanning beds. A helpful look at why not all UV exposure works the same, why that distinction matters, and how it shapes both skin health and cellular function

Catch Part 1 (Rabbit Holes – Ep. 081) HERE

Preview Only — Become a member for full access
SSRP Institute Apr 15, 2026
FDA Announces Change in Status of 12 Peptides
BREAKING NEWS APRIL 15, 2026 – In a welcome announcement to the SSRP community, the FDA reported today that it will imminently remove the following bulk drug substances from category 2: BPC-157, LL-37, DiHexa, DSIP, Epitalon, *GHK-Cu (injectable only), KPV, PEG-MGF, Melanotan II, MOTs-C, Semax, and TB-500. Originally nominated for Category 2 (Bulk Substances that […]
READ NEWS
VIDEO
Cellular Medicine Mondays
Apr 13, 2026
Ep. 083 - Safety of Low-Dose Oral Minoxidil for Hair Loss: A Multicenter Study of 1404 Patients
Preview Only
Journal Club – Episode 083

Safety of Low-Dose Oral Minoxidil for Hair Loss: A Multicenter Study of 1404 Patients

Dr. Seeds discusses this article on low dose minoxidil for hair loss and shares why a lower, slower dosing approach may lead to better outcomes. He also reviews key safety considerations, side effects, and practical dosing insights for both men and women. (Article Link)

Preview Only — Become a member for full access
SSRP Institute Apr 9, 2026
SSRP Institute Welcomes StemWave as New Trusted Partner
PARTNER ANNOUNCEMENT WILLOUGHBY, Ohio, [April 9, 2026] — The SSRP Institute announces that StemWave has joined its Trusted Partner Network following nomination and completion of the SSRP’s internal review process. StemWave provides an FDA-listed, non-invasive acoustic wave therapy platform used in musculoskeletal care. The technology delivers focused mechanical energy to targeted tissues, supporting improved circulation, […]
READ NEWS
Mastermind Mastermind
Mastermind 15: The Aesthetic Matrix
This course teaches a mechanism-informed approach to aesthetic skin aging by connecting environmental exposures and procedures with cellular stress, inflammation, and repair biology. You’ll review how UVA and UVB contribute to photoaging, how visible/blue light is discussed in pigmentation and...
10 Lessons
17 hrs 24 min
View Course
VIDEO
Cellular Medicine Mondays
Mar 30, 2026
Ep. 081 - The Cellular Impact of UVA vs. UVB Light (Part 1)
Preview Only
Rabbit Holes – Episode 081

The Cellular Impact of UVA vs. UVB Light (Part 1)

In this Rabbit Holes episode, Dr. Seeds explains the mechanistic differences between UVA and UVB light, highlighting how each spectrum uniquely contributes to photoaging, oxidative stress, DNA damage, and skin cancer risk. He also outlines cellular strategies to support antioxidant defenses, mitochondrial function, and DNA repair in response to chronic light exposure.

Want to learn more? Check out Mastermind 15 on Aesthetics!

Preview Only — Become a member for full access
ARTICLE
William Seeds, MD
Mar 25, 2026
The Truth about Ketone Esters: Not All Exogenous Products are the Same
William Seeds, MD Mar 25, 2026
The Truth about Ketone Esters: Not All Exogenous Products are the Same
The Father of Ketones and the Value of Exogenous Ketone Esters I’ve talked about ketones and ketone esters for many years, and I’ve now come to a place  where I really have to take a more direct stand on how they’ve been marketed to the wider public, and in particular, to providers who may not […]
READ ARTICLE
VIDEO
Cellular Medicine Mondays
Mar 23, 2026
Ep. 080 - BPC-157 vs. TB-500: Evaluating Unexpected Joint Symptoms
Preview Only
Dissecting Protocols – Episode 080

BPC-157 vs. TB-500: Evaluating Unexpected Joint Symptoms

Dr. Seeds reviews a case of swelling, joint stiffness, and tingling that appeared after stacking BPC-157 with TB-500, using it as a framework for thinking through peptide reactions, sourcing, and causality. (Question Link)

Preview Only — Become a member for full access

Subscribe to the SSRP Community Digest

Get the latest research and developments in the field of Cellular Medicine straight to your inbox every month.

This field is for validation purposes and should be left unchanged.